Mariner’s SBC Medical Group SBC Stock Holding History

Mariner’s Portfolio SBC Stock Details SBC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$104K	Buy	33,747 +9,787	+41%	+$33.2K	﹤0.01%	3322
2026 Q1	$100K	Buy	+23,960	New	+$100K	﹤0.01%	3326

Other funds holding SBC

Lumbard & Kellner Hollis, New Hampshire $330M AUM 65.94% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

HIM

Hillsdale Investment Management Toronto, Ontario, Canada $4.39B AUM 72.96% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Mariner's SBC Position: Q2 2026 in Review

Mariner increased its SBC Medical Group (SBC) stake by 41% in Q2 2026, buying an estimated $33.2K and bringing the position to 33,747 shares worth $104K. The position accounts for ﹤0.01% of the portfolio, ranked #3322.

Mariner first reported a position in SBC in Q1 2026 and has held it in 2 quarters since. 57 funds tracked by Wall St. Rank hold SBC as of Q2 2026.

Mariner held 33,747 shares of SBC Medical Group worth $104K as of Q2 2026.
Mariner bought 9,787 SBC Medical Group shares in Q2 2026, an estimated $33.2K.
SBC Medical Group made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #3322 holding.
Mariner first reported a position in SBC Medical Group in Q1 2026 and has held it in 2 quarters since.
57 funds tracked by Wall St. Rank held SBC Medical Group as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.